Comparison of 2 doses of PEG-interferon alfa-2b plus weight based ribavirin for treatment of previously untreated patients with genotype 1 HCV infection

被引：0
|
作者：
Cox, PP [1 ]
Do, H [1 ]
Carithers, RL [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：342A / 342A
页数：1
相关论文
共 50 条
  • [1] 24 weeks of treatment with peg-interferon alfa-2b plus ribavirin in patients infected with HCV genotype 2 and 3.
    Wiegand, J
    HEPATOLOGY, 2002, 36 (04) : 360A - 360A
  • [2] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [3] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [4] Peg-interferon alfa-2b and ribavirin in treatment naive African American patients infected with HCV genotype 1.
    Stein, DF
    McKenzie, SD
    HEPATOLOGY, 2003, 38 (04) : 642A - 642A
  • [5] Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
    Pavan, M. H. P.
    Velho, P. E. N. F.
    Vigani, A. G.
    Goncalves, F. L.
    Aoki, F. H.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03): : 383 - 384
  • [6] Two doses of PEG-Interferon alfa-2b plus rivabirin in genotype 1 naive patients with chronic hepatitis
    Buti, M
    Lurie, Y
    Sanchez, F
    Valdes, A
    Martell, M
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 102 - 102
  • [7] Peg-interferon alfa-2b and Ribavirin for the treatment of genotype 1 hepatitis C recurrence after liver transplantation
    Lodato, F.
    Berardi, S.
    Gramenzi, A.
    Mazzella, G.
    Lenzi, M.
    Morelli, M. C.
    Tame, Mr.
    Piscaglia, F.
    Andreone, P.
    Ballardini, G.
    Bernardi, M.
    Bianchi, F. B.
    Biselli, M.
    Bolondi, L.
    Cescon, M.
    Colecchia, A.
    D'Errico, A.
    Del Gaudio, M.
    Ercolani, G.
    Grazi, G. L.
    Grigioni, W.
    Lorenzini, S.
    Pinna, A. D.
    Ravaioli, M.
    Roda, E.
    Sama, C.
    Vivarelli, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A36 - A36
  • [8] EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1-COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY
    Nakajima, T.
    Kimura, M.
    Arakawa, T.
    Kuwata, Y.
    Ozeki, I.
    Sato, T.
    Ohmura, T.
    Hige, S.
    Karino, Y.
    Toyota, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S494 - S494
  • [9] HCV SPRINT-1: BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN FOR TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PREVIOUSLY UNTREATED PATIENTS
    Kwo, Paul
    Lawitz, Eric J.
    McCone, Jonathan
    Schiff, Eugene R.
    Vierling, John M.
    Pound, David
    Davis, Mitchell
    Galati, Joseph S.
    Gordon, Stuart C.
    Ravendhran, Natarajan
    Rossaro, Lorenzo
    Anderson, Frank H.
    Jacobson, Ira M.
    Rubin, Raymond
    Koury, Kenneth
    Chaudhri, Eirum I.
    Albrecht, Janice K.
    HEPATOLOGY, 2008, 48 (04) : 1027A - 1027A
  • [10] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
    Laguno, M
    Murillas, J
    Blanco, JL
    Martínez, E
    Miquel, R
    Sánchez-Tapias, JM
    Bargallo, X
    García-Criado, A
    de Lazzari, E
    Larrousse, M
    León, A
    Loncá, M
    Milinkovic, A
    Gatell, JM
    Mallolas, J
    AIDS, 2004, 18 (13) : F27 - F36
12345